Patents Examined by Luke Karpinski
  • Patent number: 8410079
    Abstract: The present invention discloses certain chirally correct polyene cyclodextrin acetals and hemiacetals (formula I) that are effective in providing skin clarification, which is useful for the treatment of acne, and skin disfigurements and skin darkening resulting from acne; skin darkening from cancer, diabetes, radiation treatments, chemotherapy, and sun-burn; mitochondrial and DNA dysfunction; age spots; loss of cellular antioxidants; skin changes associated with aging including collagen loss, loss of skin pliability, loss of skin suppleness, skin wrinkles and fine lines, oxidation, damage from radiation, damage from free radicals, and damage from UV; dry skin; xerosis; ichthyosis; dandruff; brownish spots; keratoses; melasma; lentigines; liver spots; skin pigmentation including pigmented spots, dark circles under the eyes, darkened skin, and blemishes; oily skin; warts; eczema; pruritic skin; psoriasis; inflammatory dermatoses; topical inflammation; disturbed keratinization; scalp dryness, and combinations th
    Type: Grant
    Filed: September 7, 2011
    Date of Patent: April 2, 2013
    Assignee: Island Kinetics
    Inventors: David Wayne Peter, John Dillon Stanek, Cheria L. Orozco, Shyam K. Gupta
  • Patent number: 8367044
    Abstract: The present invention provides a sunscreen cosmetic comprising, relative to the total amount of the sunscreen cosmetic, 10-90 wt % of agar microgel (wherein the agar content in the agar microgel is 0.4-1 wt %) and 0.1-5 wt % of a water soluble ultraviolet absorbent. It was necessary to blend in an organic ultraviolet absorbent and such to give sunscreen cosmetics a high SPF value. However, there was a problem in that it was hard for a water soluble ultraviolet absorbent in the formulation to achieve the expected SPF function. Also, sunscreen cosmetics are particularly desired to give a freshing texture upon use. In view of the fact that a high blend ratio of an oil soluble ultraviolet absorbent inhibits the freshing texture upon use, the object of the present invention is to provide a sunscreen cosmetic that achieves a high SPF value and a freshing texture upon use by mainly blending in a water soluble ultraviolet absorbent.
    Type: Grant
    Filed: July 26, 2010
    Date of Patent: February 5, 2013
    Assignee: Shiseido Company, Ltd.
    Inventors: Susumu Yoshida, Koji Abe, Hideto Ueda, Yuki Sugiyama, Tomiko Takakura
  • Patent number: 8357353
    Abstract: A chemical composition comprising a linker agent and a compound comprising at least one UV-absorbing chromophore, wherein the linker agent is characterized by the general formula: wherein X1 and X2 are the same or different, and at least one of X1 or X2 is a functional group that bonds with the compound comprising at least one UV-absorbing chromophore, and b+f?2, Y comprises an O, N, or S that is substituted or unsubstituted, each a, b, c, e and f is ?0 and a+b+c+e+f?2, d is 0 or 1, n1 and n2 represent the number of hydrogen atoms required to complete the undesignated valencies, and m ranges from 1 to about 100 and each individual m unit may be the same or different.
    Type: Grant
    Filed: May 10, 2010
    Date of Patent: January 22, 2013
    Assignees: Biotechnology Research & Development Corporation, United States Department of Agriculture
    Inventors: Joseph A. Laszlo, David L. Compton, Louis J. DeFilippi, Steven Grall
  • Patent number: 8349339
    Abstract: Segregation of antiperspirant actives suspended in anhydrous compositions employing ester oils or non-volatile silicone oils having a refractive index of at least 1.5, preferably together with an alcohol oil, gelled with a fibre-forming amide gellant can be inhibited by including a segregation inhibitor, especially an arylene-alkylene block copolymer, such as a tri-block copolymer e.g. a styrene/ethylenebutylene/styrene copolymer or a styrene/butylene copolymer.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: January 8, 2013
    Assignee: Conopco Inc.
    Inventors: Martin Peter Cropper, Kevin Ronald Franklin
  • Patent number: 8349369
    Abstract: This invention relates to aqueous solutions of reactive chlorine compounds having the empirical formulae H2Cl2O6 or ClO3H, for example, and the derivatives, anions or salts thereof. The invention further relates to methods for the production of said compounds and the use thereof in the pharmaceutical and particularly in the medical field, in cosmetics, medicinal care and in the domains of food technology and technology.
    Type: Grant
    Filed: October 7, 2009
    Date of Patent: January 8, 2013
    Assignee: CytoTools GmbH
    Inventors: Klaus J. Wannowius, Dirk Kaiser
  • Patent number: 8343465
    Abstract: A topical cosmetic and dermatological preparation for reducing skin reddening which comprises (1R,2S,5R)-2-isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl)-cyclohexane carboxamide and/or (1R,2S,5R)—N-(4-cyanomethyl-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: January 1, 2013
    Assignee: Beiersdorf AG
    Inventors: Ludger Kolbe, Julia Eckert, Gitta Neufang, Stefanie Knaupmeier
  • Patent number: 8323624
    Abstract: Novel s-triazine sunscreens have the structural formula (I): and are formulated into cosmetic/dermatological photoprotective compositions useful for photoprotecting keratinous substances against the damaging effects of UV-radiation.
    Type: Grant
    Filed: August 31, 2005
    Date of Patent: December 4, 2012
    Assignee: L'Oreal
    Inventors: Herve Richard, Catherine Lejuste
  • Patent number: 8309063
    Abstract: A stable, oil-in-water (O-W) emulsion-based sunscreen composition having at least one water-insoluble, organic UV-absorber having a water-solubility of much less than 0.1% by weight, contained in the oil phase of the sunscreen emulsion, comprising i) zinc oxide (ZnO) particles having a surface free of any prior coating of any inorganic oxide and hydrophobic material, remaining dispersed in the water phase of the sunscreen emulsion; ii) at least one non- or low-foaming, non-cationic, hydrophilic polymer, capable of dispersing or deflocculating the ZnO particles but incapable of thickening an aqueous composition to a viscosity of greater than 100 cps at 25° C.
    Type: Grant
    Filed: June 10, 2005
    Date of Patent: November 13, 2012
    Assignee: Amcol International Corporation
    Inventors: Ashoke K. SenGupta, Ilona Lin
  • Patent number: 8308985
    Abstract: The instant invention relates to a process for the preparation of an aqueous suspension of anionic colloidal silica having a neutral pH which is stable over time and comprises individualized particles of colloidal silica which are not bound to one another by siloxane bonds. The instant suspensions show high storage stability and are particularly useful for the clarification of beer, for the preparation of cosmetic formulations, for the production of ink for printers, for paints and for anticorrosive treatments.
    Type: Grant
    Filed: March 6, 2012
    Date of Patent: November 13, 2012
    Assignee: AZ Electronic Materials USA Corp.
    Inventors: Eric Jacquinot, Marie-Laure Perard, Uwe Falk, Torsten Henning
  • Patent number: 8293765
    Abstract: An injectable depot formulation comprising crystals having structure (I) wherein R is (FII) and the X50 value of the crystals is from 1 to 200 microns. Depot formulations containing crystals of iloperidone or its metabolites have the following advantages: (i) release of the crystals in plasma can be correlated with the size of the crystals; (ii) absorption of the crystals in plasma can be correlated with the size of the crystals; (iii) the particle size of the crystals can be controlled by crystal engineering and/or milling; and (iv) the crystals are stable upon storage, and stable to sterilization procedures, such as gamma irradiation.
    Type: Grant
    Filed: May 12, 2011
    Date of Patent: October 23, 2012
    Assignee: Novartis AG
    Inventors: Dierk Wieckhusen, Alexandra Glausch, Markus Ahlheim
  • Patent number: 8241614
    Abstract: A composition and method for imparting a sunless tan to skin is described. The composition and method make use of a sunless tanning agent like dihydroxyacetone in combination with an adjuvant such as a phosphorylated peptide.
    Type: Grant
    Filed: November 30, 2009
    Date of Patent: August 14, 2012
    Assignee: Conopco, Inc
    Inventors: Joseph Oreste Carnali, Qiang Qiu, Xi Yuan Hua
  • Patent number: 8236288
    Abstract: A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: August 7, 2012
    Assignee: Skinmedica, Inc.
    Inventors: Rahul C. Mehta, Elizabeth Tsin Ho Makino, Sujatha D. Sonti, John A. Garruto
  • Patent number: 8227488
    Abstract: An injectable depot formulation comprising crystals having structure (I) wherein R is (FII) and the X50 value of the crystals is from 1 to 200 microns. Depot formulations containing crystals of iloperidone or its metabolites have the following advantages: (i) release of the crystals in plasma can be correlated with the size of the crystals; (ii) absorption of the crystals in plasma can be correlated with the size of the crystals; (iii) the particle size of the crystals can be controlled by crystal engineering and/or milling; and (iv) the crystals are stable upon storage, and stable to sterilization procedures, such as gamma irradiation.
    Type: Grant
    Filed: February 21, 2012
    Date of Patent: July 24, 2012
    Assignee: Novartis AG
    Inventors: Dierk Wieckhusen, Alexandra Glausch, Markus Ahlheim
  • Patent number: 8221730
    Abstract: UV-photoprotective sunscreen compositions contain at least one novel silanic p-aminobenzalmalonate-substituted s-triazine compound having the general formula (I):
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: July 17, 2012
    Assignee: L'Oreal
    Inventor: Hervé Richard
  • Patent number: 8221728
    Abstract: UV-photoprotective sunscreen compositions contain at least one novel silanic p-aminobenzalmalonate-substituted s-triazine compound having the general formula (I):
    Type: Grant
    Filed: February 23, 2005
    Date of Patent: July 17, 2012
    Assignee: L'Oreal
    Inventor: Herve Richard
  • Patent number: 8221736
    Abstract: cis-Jasmone has been discovered to be useful as a semiochemical that changes the behavior of insects and/or the physiology of plants. It has direct signalling roles with plant-feeding aphids, in attraction of aphid predators and parasitoids, and may act as an airborne signal inducing production of volatile plant semiochemicals, including the monoterpene (E)-?-ocimene, that stimulate foraging by parasitoids. It is an extremely benign compound having, to human beings, a pleasant aroma and gives a long-lasting effect after removal of the stimulus.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: July 17, 2012
    Assignee: Rothamsted Research Limited
    Inventors: Alastair James Hick, John Anthony Pickett, Lester John Wadhams, Johnathan Andrew Napier
  • Patent number: 8221796
    Abstract: The present invention discloses an improved copper-based fungicide/bactericide composition. The improved composition offers higher biological activity over typical copper-based products, while requiring significantly less copper in the composition. The present invention also discloses methods of making the improved copper-based fungicide/bactericide composition. The present invention further discloses methods of using the improved copper-based fungicide/bactericide composition.
    Type: Grant
    Filed: October 23, 2008
    Date of Patent: July 17, 2012
    Assignee: Albaugh, Inc.
    Inventors: Alfonso Gutierrez Martinez, Laura Elizabeth Bailon Cisneros, Pablo Diaz Toledo, Raul Salazar Franco
  • Patent number: 8211873
    Abstract: This invention relates to certain chirally-correct mitoprotectant phosphorylated heterocyclic agents [formula (I)], which are useful for the treatment of dermatological disorders that include challenged skin from cancer, diabetes, radiation treatments, chemotherapy, and sun-burn; mitochondrial dysfunction; age spots; acne, loss of cellular antioxidants; skin changes associated with aging including collagen loss, loss of skin pliability, loss of skin suppleness, skin wrinkles and fine lines, oxidation, damage from radiation, damage from free radicals, and damage from UV; dry skin; xerosis; ichthyosis; dandruff; brownish spots; keratoses; melasma; lentigines; liver spots; skin pigmentation including pigmented spots, dark circles under the eyes, darkened skin, and blemishes; oily skin; warts; eczema; pruritic skin; psoriasis; inflammatory dermatoses; topical inflammation; disturbed keratinization; scalp dryness; skin depigmentation, and combinations thereof;
    Type: Grant
    Filed: August 6, 2010
    Date of Patent: July 3, 2012
    Assignee: Island Kinetics, inc.
    Inventors: Shyam K Gupta, Linda Walker
  • Patent number: 8207212
    Abstract: Methods for preventing damage to the epidermis during PDT induced using a pre-photosensitizing agent are provided. The methods of the present invention utilize spatial confinement to control formation of a photoactive species from a topically-applied pre-photosensitizing agent. In one embodiment, thermal inhibition is used to prevent the metabolism of a pre-photosensitizing agent in epithelial tissue surrounding a treatment site. In another embodiment, a chemical inhibitor can be applied to the epithelial tissue to inhibit the conversion of a pre-photosensitizing agent into a phototoxic species.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: June 26, 2012
    Assignee: The General Hospital Corporation
    Inventors: Richard Rox Anderson, Bernhard Ortel, Eliot F. Battle, Edwin K. Joe
  • Patent number: 8192766
    Abstract: The present invention discloses an improved copper-based fungicide/bactericide composition. The improved composition offers higher biological activity over typical copper-based products, while requiring significantly less copper in the composition. The present invention also discloses methods of making the improved copper-based fungicide/bactericide composition. The present invention further discloses methods of using the improved copper-based fungicide/bactericide composition.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: June 5, 2012
    Assignee: Albaugh, Inc.
    Inventors: Alfonso Gutierrez Martinez, Laura Elizabeth Bailon Cisneros, Pablo Diaz Toledo, Raul Salazar Franco